News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,312 Results
Type
Article (87550)
Company Profile (827)
Press Release (774916)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233106)
Career Advice (4140)
Deals (39813)
Drug Delivery (141)
Drug Development (91287)
Employer Resources (203)
FDA (18301)
Job Trends (17407)
News (397505)
Policy (39931)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (130)
Alliances (56980)
ALS (147)
Alzheimer's disease (1693)
Antibody-drug conjugate (ADC) (269)
Approvals (18340)
Artificial intelligence (517)
Autoimmune disease (107)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (139)
Brain cancer (53)
Breast cancer (532)
Cancer (4197)
Cardiovascular disease (367)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (715)
Cervical cancer (33)
Clinical research (75861)
Collaboration (1457)
Company closure (4)
Compensation (969)
Complete response letters (63)
COVID-19 (2966)
CRISPR (85)
C-suite (632)
Cystic fibrosis (142)
Data (4999)
Decentralized trials (2)
Denatured (65)
Depression (114)
Diabetes (470)
Diagnostics (7114)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (248)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (209)
Earnings (99420)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (133601)
Executive appointments (1000)
FDA (20901)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (1311)
Gene editing (181)
Generative AI (52)
Gene therapy (570)
GLP-1 (1045)
Government (5396)
Grass and pollen (8)
Guidances (374)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (68)
Immunology and inflammation (258)
Immuno-oncology (22)
Indications (60)
Infectious disease (3218)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (103)
Intellectual property (201)
Interviews (816)
IPO (17932)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (92)
Longevity (13)
Lung cancer (595)
Lymphoma (289)
Machine learning (33)
Management (66)
Manufacturing (675)
MASH (148)
Medical device (14916)
Medtech (14945)
Mergers & acquisitions (22797)
Metabolic disorders (1208)
Multiple sclerosis (141)
NASH (23)
Neurodegenerative disease (239)
Neuropsychiatric disorders (63)
Neuroscience (2774)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (583)
Opinion (316)
Ovarian cancer (144)
Pain (173)
Pancreatic cancer (179)
Parkinson's disease (248)
Partnered (32)
Patents (433)
Patient recruitment (342)
Peanut (57)
People (66379)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23399)
Phase II (32917)
Phase III (24826)
Pipeline (3003)
Policy (306)
Postmarket research (3554)
Preclinical (10577)
Press Release (72)
Prostate cancer (206)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (717)
Real estate (7423)
Recruiting (79)
Regulatory (28162)
Reports (65)
Research institute (2698)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1067)
Venture capital (69)
Weight loss (413)
Women's health (63)
Worklife (21)
Date
Today (250)
Last 7 days (1214)
Last 30 days (3545)
Last 365 days (33769)
2025 (28848)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (311)
Arkansas (14)
Asia (51087)
Australia (8982)
California (10025)
Canada (2961)
China (955)
Colorado (419)
Connecticut (445)
Delaware (286)
Europe (117442)
Florida (1470)
Georgia (326)
Hawaii (3)
Idaho (67)
Illinois (832)
India (56)
Indiana (491)
Iowa (20)
Japan (339)
Kansas (127)
Kentucky (39)
Louisiana (23)
Maine (80)
Maryland (1334)
Massachusetts (7476)
Michigan (321)
Minnesota (593)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (80)
New Jersey (2758)
New Mexico (32)
New York (2689)
North Carolina (1456)
North Dakota (10)
Northern California (4631)
Ohio (310)
Oklahoma (22)
Oregon (51)
Pennsylvania (2062)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3826)
Tennessee (153)
Texas (1562)
United States (36708)
Utah (300)
Virginia (256)
Washington D.C. (84)
Washington State (853)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
There are 863,312 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NEURELIS TO PRESENT STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT SYMPTOMATIC CEREBRAL CAVERNOUS MALFORMATIONS (CCM), AT ANNUAL CCM MEETING
November 7, 2025
·
7 min read
Press Releases
NeoGenomics to Participate in Upcoming Investor Conferences - November 6, 2025
November 7, 2025
·
1 min read
Press Releases
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 7, 2025
·
7 min read
Press Releases
Neurogene Announces First Participant Dosed in Embolden™ Registrational Trial of NGN-401 Gene Therapy for Rett Syndrome
November 7, 2025
·
7 min read
Press Releases
ELEPHAS BIOSCIENCES RAISES $40M TO ACCELERATE COMMERCIALIZATION OF ITS LIVE TUMOR PROFILING PLATFORM
November 7, 2025
·
2 min read
Press Releases
Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year”
November 7, 2025
·
3 min read
Press Releases
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart
November 7, 2025
·
9 min read
Press Releases
Montai Therapeutics Presents Preclinical Data on NRF2 Agonist in Ulcerative Colitis at ACAAI Annual Meeting
November 7, 2025
·
3 min read
Press Releases
ReAlta Life Sciences to Present RLS-0071 (pegtarazimod) Clinical Data at 2025 American Society of Hematology Annual Meeting
November 7, 2025
·
1 min read
Press Releases
Ionis presents new data demonstrating long-term disease control with DAWNZERA™ (donidalorsen) at ACAAI 2025 Annual Meeting
November 7, 2025
·
6 min read
1 of 86,332
Next
